Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


DesRosier Thomas Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2023 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 42,500 restricted stock units @ $0
Granted 85,000 options to buy @ $5.5, valued at $467.5k
07/06/2022 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 63,492 shares @ $3.15, valued at $200k
02/08/2022 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 130,000 options to buy @ $7.38, valued at $959.4k
02/08/2021 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $26.34, valued at $2.6M
01/31/2020 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $3.3, valued at $1.2M
01/28/2020 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Exercised 25,000 restricted stock units @ $0
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2018 4 DesRosier Thomas (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 3,475 shares @ $11.02, valued at $38.3k
Exercised 10,000 restricted stock units @ $0
Granted 80,000 options to buy @ $10.42, valued at $833.6k
Granted 100,000 options to buy @ $10.42, valued at $1M
01/27/2017 4 DesRosier Thomas (Chief Legal Officer and EVP) has filed a Form 4 on Seres Therapeutics, Inc.
06/02/2016 4 DesRosier Thomas (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $30.9, valued at $3.1M
03/30/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/09/2016 4 DesRosier Thomas (EVP, General Counsel) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
Txns: Granted 102,500 options to buy @ $6.51, valued at $667.3k
Granted 30,800 restricted stock units @ $0
10/02/2013 4 DesRosier Thomas (SVP, Chief Legal Officer & GC) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Acquired 93 shares @ $63.55, valued at $5.9k
04/16/2013 4 DesRosier Thomas (SVP, Chief Legal Counsel & GC) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Granted 70,207 options to buy @ $45.9, valued at $3.2M
Granted 9,509 restricted stock units @ $0
03/27/2013 3 Form 3 - Initial statement of beneficial ownership of securities
04/06/2011 4 DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP
Txns: Unknown transaction of 5,738 shares @ $74, valued at $424.6k
Disposed/sold 11,375 shares @ $74, valued at $841.8k
Unknown transaction of 4,947 shares @ $74, valued at $366.1k
Unknown transaction of 779 shares @ $74, valued at $57.6k
Exercised 5,542 restricted stock units @ $0
Exercised 5,833 restricted stock units @ $0
Disposed/sold 23,038 options to buy @ $51.52, valued at $1.2M
Disposed/sold 16,625 options to buy @ $58.66, valued at $975.2k
Disposed/sold 17,500 options to buy @ $68.48, valued at $1.2M
Disposed/sold 17,500 options to buy @ $62.16, valued at $1.1M
Disposed/sold 35,000 options to buy @ $58.5, valued at $2M
06/18/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2010 4 DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP
Txns: Sold 1,972 shares @ $45.6, valued at $89.9k
Exercised 5,833 restricted stock units @ $0
05/26/2009 4 DesRosier Thomas (Sr VP, General Counsel) has filed a Form 4 on GENZYME CORP
04/29/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy